135 related articles for article (PubMed ID: 2423985)
1. Amiodarone: value of programmed electrical stimulation and Holter monitoring.
Fisher JD; Kim SG; Waspe LE; Johnston DR
Pacing Clin Electrophysiol; 1986 May; 9(3):422-35. PubMed ID: 2423985
[TBL] [Abstract][Full Text] [Related]
2. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
[TBL] [Abstract][Full Text] [Related]
3. Ventricular arrhythmias: use of electrophysiologic studies.
Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
[TBL] [Abstract][Full Text] [Related]
4. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
6. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
Hamer AW; Finerman WB; Peter T; Mandel WJ
Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone in refractory life-threatening ventricular arrhythmias.
Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
[TBL] [Abstract][Full Text] [Related]
8. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Feb; 9(2):398-404. PubMed ID: 3805529
[TBL] [Abstract][Full Text] [Related]
9. Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy.
Reddy CP; Kuo CS; Jivrajka V
Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 1):1055-62. PubMed ID: 6209624
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone therapy: role of early and late electrophysiologic studies.
Greenspon AJ; Volosin KJ; Greenberg RM; Jefferies L; Rotmensch HH
J Am Coll Cardiol; 1988 Jan; 11(1):117-23. PubMed ID: 3335688
[TBL] [Abstract][Full Text] [Related]
11. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
Fananapazir L; Epstein SE
Am J Cardiol; 1991 Jan; 67(2):175-82. PubMed ID: 1987719
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Morady F; Scheinman MM; Hess DS
Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
Yazaki Y; Haffajee CI; Gold RL; Bishop RL; Alpert JS
Am J Cardiol; 1987 Aug; 60(4):293-7. PubMed ID: 3618488
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class 1A antiarrhythmic agent.
Kim SG; Felder SD; Figura I; Johnston DR; Mercando AD; Fisher JD
Am J Cardiol; 1987 Jun; 59(15):1314-8. PubMed ID: 3591686
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
Rowland E; Krikler DM
Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
17. Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis.
Roberts SA; Viana MA; Nazari J; Bauman JL
Pacing Clin Electrophysiol; 1994 Oct; 17(10):1590-602. PubMed ID: 7800560
[TBL] [Abstract][Full Text] [Related]
18. Clinical use and pharmacology of amiodarone.
Heger JJ; Prystowsky EN; Miles WM; Zipes DP
Med Clin North Am; 1984 Sep; 68(5):1339-66. PubMed ID: 6387328
[TBL] [Abstract][Full Text] [Related]
19. QT prolongation and the antiarrhythmic efficacy of amiodarone.
Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
[TBL] [Abstract][Full Text] [Related]
20. [The place of amiodarone in 1979 in the therapeutic arsenal of a cardiac intensive care unit].
Demoulin JC; Legrand V
Rev Med Liege; 1979 Dec; 34(23):963-8. PubMed ID: 550265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
